Diabetic Macular Ischemia Clinical Trial
Official title:
Evaluation of the Effects of Oxygen Therapy and Enalapril for Diabetic Macular Ischemia
In this study, patients were divided into 3 group with 35 cases including: 1.oxygen
2.enalapril 3.control.
In the beginning of the study, best corrected visual acuity (BCVA), uncorrected visual
acuity (UCVA), and optical coherence tomography (OCT) were measured. Patients in the oxygen
group were given oxygen 10 lit/min 1 hour twice a day at the first month, once a day at the
second month and every other day at the third month. In the enalapril group, patients were
given enalapril 5 mg every night and placebo was given for the patients in third group. At
the end of first month the patients' vision was checked again and at the the end of the
third month the first physical examinations were performed. In the first group, arterial
blood gas (ABG) was taken before and after oxygen therapy as well.
n/a
N/A